These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3035612)

  • 1. Neurotoxicant sensitive esterase. Enzymology and pathophysiology of organophosphorus ester-induced delayed neuropathy.
    Zech R; Chemnitius JM
    Prog Neurobiol; 1987; 29(2):193-218. PubMed ID: 3035612
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative sensitivities of avian neural esterases to in vitro inhibition by organophosphorus compounds.
    Correll L; Ehrich M
    Toxicol Lett; 1987 Apr; 36(2):197-204. PubMed ID: 3576651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood copper in organophosphate-induced delayed polyneuropathy.
    Lotti M; Caroldi S; Moretto A
    Toxicol Lett; 1988 May; 41(2):175-80. PubMed ID: 2835831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathy target esterase (NTE) and organophosphorus-induced delayed polyneuropathy (OPIDP): recent advances.
    Johnson MK; Glynn P
    Toxicol Lett; 1995 Dec; 82-83():459-63. PubMed ID: 8597094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotoxic esterase in peripheral nerve: assay, inhibition, and rate of resynthesis.
    Caroldi S; Lotti M
    Toxicol Appl Pharmacol; 1982 Mar; 62(3):498-501. PubMed ID: 7071865
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation of organophosphorus-induced delayed neurotoxicity following phenyl saligenin phosphate exposures in 2-, 5-, and 8-week-old chickens.
    Harp P; Tanaka D; Pope CN
    Fundam Appl Toxicol; 1997 May; 37(1):64-70. PubMed ID: 9193923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathy target esterase inhibition by organophosphorus esters in human neuroblastoma cells.
    Ehrich M; Correll L; Veronesi B
    Neurotoxicology; 1994; 15(2):309-13. PubMed ID: 7991219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of verapamil on organophosphorus-induced delayed neuropathy in hens.
    el-Fawal HA; Jortner BS; Ehrich M
    Toxicol Appl Pharmacol; 1989 Mar; 97(3):500-11. PubMed ID: 2558427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a model cell culture system in which to study early effects of neuropathy-inducing organophosphorus esters.
    Nostrandt AC; Ehrich M
    Toxicol Lett; 1992 Jan; 60(1):107-14. PubMed ID: 1539177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axonal degeneration and neuropathy target esterase.
    Glynn P
    Arh Hig Rada Toksikol; 2007 Sep; 58(3):355-8. PubMed ID: 18050888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of the activity of neurotoxic esterase in the peripheral blood lymphocytes for assessing the action of organophosphorus compounds].
    Tkachenko II; Kokshareva NV; Zinchenko DV; Zinov'eva ML; Kagan IuS
    Vrach Delo; 1989 Sep; (9):107-10. PubMed ID: 2609604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Early manifestations and mechanism of the neurotoxic action of organophosphorus pesticides].
    Kagan IuS; Kokshareva NV; Tkachenko II
    Biull Eksp Biol Med; 1986 Sep; 102(9):310-2. PubMed ID: 3019451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing for organophosphate-induced delayed polyneuropathy.
    Moretto A
    Curr Protoc Toxicol; 2001 May; Chapter 11():Unit11.5. PubMed ID: 20957642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor characteristics of native, solubilized, and lipid-reconstituted neurotoxic esterase.
    Davis CS; Barth ML; Dudek BR; Richardson RJ
    Dev Toxicol Environ Sci; 1980; 8():63-6. PubMed ID: 7308073
    [No Abstract]   [Full Text] [Related]  

  • 15. [Delayed polyneuropathy induced by organophosphorus esters].
    Lotti M
    Riv Neurobiol; 1982; 28(3-4):498-506. PubMed ID: 6195725
    [No Abstract]   [Full Text] [Related]  

  • 16. Postscript to the symposium on organophosphorus compound induced delayed neuropathy.
    Aldridge N
    Chem Biol Interact; 1993 Jun; 87(1-3):463-6. PubMed ID: 8344004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "In vitro" inhibition of neurotoxic esterase by organophosphorus nerve agents.
    Vranken MA; De Bisschop HC; Willems JL
    Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):316-8. PubMed ID: 7165440
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of organophosphate compounds with remote neurotoxicity].
    Kokshareva NV; Tkachenko II; Kagan IuS; Zinov'eva ML
    Gig Sanit; 1988 Oct; (10):83-4. PubMed ID: 3234793
    [No Abstract]   [Full Text] [Related]  

  • 19. Species susceptibility to delayed toxic neuropathy in relation to in vivo inhibition of neurotoxic esterase by neurotoxic organophosphorus esters.
    Soliman SA; Linder R; Farmer J; Curley A
    J Toxicol Environ Health; 1982 Feb; 9(2):189-97. PubMed ID: 7077681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The concept and target of promotion of axonopathies.
    Lotti M
    Arch Toxicol Suppl; 1997; 19():331-6. PubMed ID: 9079220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.